A single ascending dose, randomized, double-blind, placebo-controlled, phase I clinical trial in healthy male Japanese volunteers to determine the safety, tolerability, and pharmacokinetic parameters of naldemedine.
Phase of Trial: Phase I
Latest Information Update: 24 Oct 2017
At a glance
- Drugs Naldemedine (Primary)
- Indications Constipation
- Focus Adverse reactions; Pharmacodynamics
- 24 Oct 2017 New trial record